Research Article
Prolonged P Wave Peak Time May Be a Sign of LV Diastolic Dysfunction in the Coronary Slow Flow Phenomenon
Table 5
Multivariable linear regression analysis.
| Variables | | PWPT in lead D2 | | PWPT in lead V1 | β coefficient | (95% CI) | value | β coefficient | (95% CI) | value |
| Mean TFC | 0.33 | 0.44–1.33 | <0.001 | 0.29 | 0.39–1.59 | 0.01 | E/e | 0.23 | 0.25–1.85 | 0.01 | 0.21 | 0.11–2.33 | 0.03 | EF | −0.14 | −1.04–−0.053 | 0.03 | −0.04 | −0.91–0.43 | 0.48 | LAAPD | 0.07 | −0.74–0.24 | 0.33 | −0.02 | −0.78–0.58 | 0.77 | Age | 0.08 | −0.48–0.24 | 0.18 | 0.13 | −0.01–0.38 | 0.06 | Gender, male | 0.09 | −0.60–4.70 | 0.13 | −0.08 | −5.81–1.35 | 0.22 | Heart rate | −0.13 | −0.29–−0.01 | 0.03 | −0.05 | −0.27–−0.10 | 0.36 | Beta-blocker | −0.03 | −4.23–2.60 | 0.64 | −0.02 | −5.55–3.80 | 0.79 | Non-DHD CCB | −0.03 | −4.71–2.78 | 0.62 | −0.02 | −5.03–3.60 | 0.70 |
|
|
Bold values are statistically significant ( P < 0.05). TFC, TIMI frame count; PWPT, wave peak time; EF, ejection fraction; LAAPD, left atrial anterior-posterior diameter; non-DHD CCB, nondihydropyridine calcium channel blocker. |